Karen Silence
- Immunology top 10%
- Molecular Biology
- Oncology top 10%
- Hematology top 5%
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Christian RolfoPeter J. LentingJanine J. J. HulsteinRob FijnheerPatrick PauwelsD CollenEvelien SmitsSylvie Rottey
- Topics
- Monoclonal and Polyclonal Antibodies Research (7 papers)Protease and Inhibitor Mechanisms (6 papers)Blood properties and coagulation (3 papers)
- Cited by
- HematologyImmunologyOncology
- Partner nations
- BelgiumNetherlandsGermany
In The Last Decade
Karen Silence
25 papers receiving 969 citations
Peers
Comparison fields: 5 of 65
- Immunology 368
- Molecular Biology 328
- Oncology 299
- Hematology 266
- Radiology, Nuclear Medicine and Imaging 153
Countries citing papers authored by Karen Silence
This map shows the geographic impact of Karen Silence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Silence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Silence more than expected).
Fields of papers citing papers by Karen Silence
This network shows the impact of papers produced by Karen Silence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Silence. The network helps show where Karen Silence may publish in the future.
Co-authorship network of co-authors of Karen Silence
This figure shows the co-authorship network connecting the top 25 collaborators of Karen Silence. A scholar is included among the top collaborators of Karen Silence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Silence. Karen Silence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 4 | |
| 3 | 47 | |
| 4 | 9 | |
| 5 | 3 | |
| 6 | 142 | |
| 7 | 30 | |
| 8 | 10 | |
| 9 | 76 | |
| 10 | 23 | |
| 11 | 82 | |
| 12 | 109 | |
| 13 | 1 | |
| 14 | 36 | |
| 15 | Molecular conversions of recombinant staphylokinase in purified systems and in human plasma during plasminogen activation | 1 |
| 16 | 9 | |
| 17 | 22 | |
| 18 | 39 | |
| 19 | 7 | |
| 20 | 53 |
About Karen Silence
Karen Silence is a scholar working on Cancer Research, Hematology and Immunology, having authored 26 papers that have together received 1000 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), Protease and Inhibitor Mechanisms (6 papers) and Blood properties and coagulation (3 papers). The work is most often cited by research in Hematology (266 citations), Immunology (368 citations) and Oncology (299 citations). Karen Silence has collaborated with scholars based in Belgium, Netherlands and Germany. Frequent co-authors include Christian Rolfo, Peter J. Lenting, Janine J. J. Hulstein, Rob Fijnheer, Patrick Pauwels, D Collen, Evelien Smits, Sylvie Rottey, Julie Jacobs and Karen Zwaenepoel. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.